Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
AbbVie North Chicago plant has second fire
An AbbVie ($ABBV) manufacturing facility in North Chicago had a fire in a laboratory this week.
Merck's Keytruda beats out chemotherapy in lung cancer study
Merck's cancer immunotherapy Keytruda beat out standard of care chemotherapy in extending time without worsening symptoms and overall survival among patients with previously untreated non-small ce...
Pfizer begins construction on $200 million biologics plant in MA
Pfizer on Thursday began construction on a new clinical manufacturing facility in Andover, Massachusetts, saying it would invest $200 million in building out the site.
FDA clears Gilotrif as late stage non-small cell lung cancer therapy
The US Food and Drug Administration (FDA) has cleared Boehringer Ingelheim's tyrosine kinase inhibitor Gilotrif (afatinib) as a new medication for patients with late stage (met...
FDA approves vaccine to prevent cholera for travelers
The U.
Can coffee cause cancer? Only if it's very hot, says WHO agency
There is no conclusive evidence that drinking coffee causes cancer, the World Health Organization's cancer agency said on Wednesday in a reverse of its previous warning, but it also said all "...
Ertugliflozin shows significant A1C reductions in patients with type 2 diabetes in two phase 3 trials
Two phase 3 clinical trials evaluating ertugliflozin for the treatment of type 2 diabetes met their primary endpoints demonstrating statistically significant reductions in blood glucose (A1C).
Sirukumab meets both co-primary endpoints in rheumatoid arthritis study
A phase III clinical trial evaluating sirukumab in adult patients with moderately to severely active rheumatoid arthritis (RA) met both co-primary endpoints.
Blood test that detects early Alzheimer's disease developed
Researchers have developed a blood test that leverages the body's immune response system to detect an early stage of Alzheimer's disease - referred to as the mild cognitive impairment (MCI...
U.S. regulator says too many drugmakers chasing same cancer strategy
By Deena BeasleyA new type of cancer drug that takes the brakes off the body's immune system has given drugmakers some remarkable wins against the deadly disease, but a top U.
Shire to License PF-00547659 from Pfizer, Adding to Established and Leading Gastrointestinal Portfolio
Lexington, Massachusetts, US – June 14, 2016 – Shire plc (LSE.
FDA, Teva Pharmaceuticals announce sales suspension of Zecuity patch
The FDA and Teva Pharmaceuticals announced that Teva has voluntarily suspended sales, marketing and distribution of the Zecuity patch.
618
619
620
621
622
623
624
625
626
